Quetiapine Fumarate API Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Table of Contents

1 RESEARCH SCOPE

• 1.1 Research Product Definition
• 1.2 Research Segmentation
  • 1.2.1 Product Type
  • 1.2.2 Main product Type of Major Players
• 1.3 Demand Overview
• 1.4 Research Methodology

2 GLOBAL QUETIAPINE FUMARATE API INDUSTRY

• 2.1 Summary about Quetiapine Fumarate API Industry
• 2.2 Quetiapine Fumarate API Market Trends
  • 2.2.1 Quetiapine Fumarate API Production & Consumption Trends
  • 2.2.2 Quetiapine Fumarate API Demand Structure Trends
• 2.3 Quetiapine Fumarate API Cost & Price

3 MARKET DYNAMICS

• 3.1 Manufacturing & Purchasing Behavior in 2020
• 3.2 Market Development under the Impact of COVID-19
  • 3.2.1 Drivers
  • 3.2.2 Restraints
  • 3.2.3 Opportunity
  • 3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

• 4.1 Region Segmentation (2017 to 2021f)
  • 4.1.1 North America (U.S., Canada and Mexico)
  • 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  • 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  • 4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  • 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
• 4.2 Product Type Segmentation (2017 to 2021f)
  • 4.2.1 Purity≥98%
  • 4.2.2 Purity≥99%
• 4.3 Consumption Segmentation (2017 to 2021f)
  • 4.3.1 Quetiapine Fumarate Tablets
  • 4.3.2 Others

5 NORTH AMERICA MARKET SEGMENT

• 5.1 Region Segmentation (2017 to 2021f)
  • 5.1.1 U.S.
  • 5.1.2 Canada
  • 5.1.3 Mexico
• 5.2 Product Type Segmentation (2017 to 2021f)
  • 5.2.1 Purity≥98%
  • 5.2.2 Purity≥99%
• 5.3 Consumption Segmentation (2017 to 2021f)
  • 5.3.1 Quetiapine Fumarate Tablets
  • 5.3.2 Others
• 5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

• 6.1 Region Segmentation (2017 to 2021f)
  • 6.1.1 Germany
  • 6.1.2 UK
  • 6.1.3 France
  • 6.1.4 Italy
  • 6.1.5 Rest of Europe
• 6.2 Product Type Segmentation (2017 to 2021f)
  • 6.2.1 Purity≥98%
  • 6.2.2 Purity≥99%
• 6.3 Consumption Segmentation (2017 to 2021f)
  • 6.3.1 Quetiapine Fumarate Tablets
  • 6.3.2 Others
• 6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

• 7.1 Region Segmentation (2017 to 2021f)
  • 7.1.1 China
  • 7.1.2 India
  • 7.1.3 Japan
  • 7.1.4 South Korea
  • 7.1.5 Southeast Asia
  • 7.1.6 Australia
  • 7.1.7 Rest of Asia Pacific
• 7.2 Product Type Segmentation (2017 to 2021f)
  • 7.2.1 Purity≥98%
  • 7.2.2 Purity≥99%
• 7.3 Consumption Segmentation (2017 to 2021f)
  • 7.3.1 Quetiapine Fumarate Tablets
  • 7.3.2 Others
• 7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

• 8.1 Region Segmentation (2017 to 2021f)
  • 8.1.1 Brazil
  • 8.1.2 Argentina
  • 8.1.3 Rest of Latin America
• 8.2 Product Type Segmentation (2017 to 2021f)
  • 8.2.1 Purity≥98%
  • 8.2.2 Purity≥99%
• 8.3 Consumption Segmentation (2017 to 2021f)
  • 8.3.1 Quetiapine Fumarate Tablets
  • 8.3.2 Others
• 8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

• 9.1 Region Segmentation (2017 to 2021f)
  • 9.1.1 GCC
  • 9.1.2 North Africa
  • 9.1.3 South Africa
  • 9.1.4 Rest of Middle East and Africa
• 9.2 Product Type Segmentation (2017 to 2021f)
  • 9.2.1 Purity≥98%
  • 9.2.2 Purity≥99%
• 9.3 Consumption Segmentation (2017 to 2021f)
  • 9.3.1 Quetiapine Fumarate Tablets
  • 9.3.2 Others
• 9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

• 10.1 Brief Introduction of Major Players
  • 10.1.1 Dr. Reddy’s
  • 10.1.2 Tapi Teva
  • 10.1.3 Tecoland
  • 10.1.4 Aarti Industries
  • 10.1.5 Hikal
  • 10.1.6 Uquifa
  • 10.1.7 Menadiona
  • 10.1.8 Sumitomo Chemical
  • 10.1.9 Zhejiang Suporpharm
  • 10.1.10 Suanfarma Group
  • 10.1.11 Sibram Pharmaceutical
  • 10.1.12 Hinsun USA
  • 10.1.13 Jubilant Pharma
  • 10.1.14 Qilu Pharmaceutical
• 10.2 Quetiapine Fumarate API Sales Date of Major Players (2017-2020e)
  • 10.2.1 Dr. Reddy’s
  • 10.2.2 Tapi Teva
  • 10.2.3 Tecoland
  • 10.2.4 Aarti Industries
  • 10.2.5 Hikal
  • 10.2.6 Uquifa
  • 10.2.7 Menadiona
  • 10.2.8 Sumitomo Chemical
  • 10.2.9 Zhejiang Suporpharm
  • 10.2.10 Suanfarma Group
  • 10.2.11 Sibram Pharmaceutical
  • 10.2.12 Hinsun USA
  • 10.2.13 Jubilant Pharma
  • 10.2.14 Qilu Pharmaceutical
• 10.3 Market Distribution of Major Players
• 10.4 Global Competition Segmentation

11 MARKET FORECAST

• 11.1 Forecast by Region
• 11.2 Forecast by Demand
• 11.3 Environment Forecast
  • 11.3.1 Impact of COVID-19
  • 11.3.2 Geopolitics Overview
  • 11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

1.Table Quetiapine Fumarate API Product Type Overview

2.Table Quetiapine Fumarate API Product Type Market Share List

3.Table Quetiapine Fumarate API Product Type of Major Players

4.Table Brief Introduction of Dr. Reddy’s

5.Table Brief Introduction of Tapi Teva

6.Table Brief Introduction of Tecoland

7.Table Brief Introduction of Aarti Industries

8.Table Brief Introduction of Hikal

9.Table Brief Introduction of Uquifa

10.Table Brief Introduction of Menadiona

11.Table Brief Introduction of Sumitomo Chemical

12.Table Brief Introduction of Zhejiang Suporpharm

13.Table Brief Introduction of Suanfarma Group

14.Table Brief Introduction of Sibram Pharmaceutical

15.Table Brief Introduction of Hinsun USA

16.Table Brief Introduction of Jubilant Pharma

17.Table Brief Introduction of Qilu Pharmaceutical

18.Table Products & Services of Dr. Reddy’s

19.Table Products & Services of Tapi Teva

20.Table Products & Services of Tecoland

21.Table Products & Services of Aarti Industries

22.Table Products & Services of Hikal

23.Table Products & Services of Uquifa

24.Table Products & Services of Menadiona

25.Table Products & Services of Sumitomo Chemical

26.Table Products & Services of Zhejiang Suporpharm

27.Table Products & Services of Suanfarma Group

28.Table Products & Services of Sibram Pharmaceutical

29.Table Products & Services of Hinsun USA

30.Table Products & Services of Jubilant Pharma

31.Table Products & Services of Qilu Pharmaceutical

32.Table Market Distribution of Major Players

33.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

34.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

35.Table Global Quetiapine Fumarate API Market Forecast (Million USD) by Region 2021f-2026f

36.Table Global Quetiapine Fumarate API Market Forecast (Million USD) Share by Region 2021f-2026f

37.Table Global Quetiapine Fumarate API Market Forecast (Million USD) by Demand 2021f-2026f

38.Table Global Quetiapine Fumarate API Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure

1.Figure Global Quetiapine Fumarate API Market Size under the Impact of COVID-19, 2017-2021f (USD Million)

2.Figure Global Quetiapine Fumarate API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)

3.Figure Global Quetiapine Fumarate API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)

4.Figure Global Quetiapine Fumarate API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)

5.Figure Global Quetiapine Fumarate API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)

6.Figure Global Quetiapine Fumarate API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)

7.Figure Global Quetiapine Fumarate API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)

8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

13.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

14.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

15.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

20.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

21.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

22.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

29.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

30.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

31.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

32.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

40.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

41.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

42.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

43.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

47.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

48.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

49.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

55.Figure Purity≥98% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

56.Figure Purity≥99% Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

57.Figure Quetiapine Fumarate Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

58.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

59.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Dr. Reddy’s 2017-2020e

60.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Tapi Teva 2017-2020e

61.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Tecoland 2017-2020e

62.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Aarti Industries 2017-2020e

63.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Hikal 2017-2020e

64.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Uquifa 2017-2020e

65.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Menadiona 2017-2020e

66.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Sumitomo Chemical 2017-2020e

67.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Zhejiang Suporpharm 2017-2020e

68.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Suanfarma Group 2017-2020e

69.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Sibram Pharmaceutical 2017-2020e

70.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Hinsun USA 2017-2020e

71.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Jubilant Pharma 2017-2020e

72.Figure Quetiapine Fumarate API Sales Revenue (Million USD) of Qilu Pharmaceutical 2017-2020e

73.